Mail Stop 4-6 April 20, 2005 Francis F. Lee President and Chief Executive Officer 2381 Bering Drive San Jose, CA 95131 Re: Synaptics, Inc. Amendment No. 1 to Registration Statement on Form S-3 Filed on March 31, 2005 File No. 333-122348 Dear Mr. Lee: We have reviewed your responses and have the following comments. 1. We are in receipt of your request for confidential treatment of Exhibit 10.22 filed in a Form 8-K on April 1, 2005. We will provide comments on the confidential treatment request, if any, in a separate letter. Please note that the confidential treatment request must be processed before effectiveness of the registration statement. 2. See prior comment 4. We note your revision to footnote 6 to the selling securityholder table indicating that Bear, Stearns & Co. and KBC Financial Products USA "may be deemed to be, under the interpretations of the Securities and Exchange Commission," underwriters. Please revise to state unambiguously here and in the plan of distribution on page 77 that these broker-dealer selling shareholders are underwriters. 3. See prior comment 7. Please revise to incorporate the Item 1.01 Form 8-K filed April 1, 2005 and any other periodic reports "filed" prior to effectiveness. We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filings reviewed by the staff to be certain that they have provided all information investors require for an informed decision. Since the company and its management are in possession of all facts relating to a company`s disclosure, they are responsible for the accuracy and adequacy of the disclosures they have made. Any questions should be directed to Maryse Mills-Apenteng at (202) 942-1861. In her absence please contact the undersigned at (202) 942-1800. Sincerely, Barbara C. Jacobs Assistant Director cc: Via facsimile: 602-445-8603 Brian Blaney, Esq. Greenberg Traurig, LLP ?? ?? ?? ?? Synaptics, Inc. April 20, 2005 Page 2 of 2
This website contains forward-looking statements that are subject to the safe harbors created under the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended. Forward-looking statements give our current expectations and projections relating to our financial condition, results of operations, plans, objectives, future performance and business, and can be identified by the fact that they do not relate strictly to historical or current facts. Such forward-looking statements may include words such as "expect," "anticipate," "intend," "believe," "estimate," "plan," "target," "strategy," "continue," "may," "will," "should," variations of such words, or other words and terms of similar meaning. All forward-looking statements reflect our best judgment and are based on several factors relating to our operations and business environment, all of which are difficult to predict and many of which are beyond our control. Such factors include, but are not limited to, the risks as identified in the "Risk Factors," "Management's Discussion and Analysis of Financial Condition and Results of Operations" and "Business" sections of our Annual Report on Form 10-K for our most recent fiscal year, and other risks as identified from time to time in our Securities and Exchange Commission reports. Forward-looking statements are based on information available to us on the date hereof, and we do not have, and expressly disclaim, any obligation to publicly release any updates or any changes in our expectations, or any change in events, conditions, or circumstances on which any forward-looking statement is based. Our actual results and the timing of certain events could differ materially from the forward-looking statements. These forward-looking statements do not reflect the potential impact of any mergers, acquisitions, or other business combinations that had not been completed as of the date of this filing.